GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
107 hedge funds and large institutions have $270M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
-7
Holders Change %
-6.14%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
41
Reduced
35
Closed
18
Calls
$1.07M
Puts
$1.13M
Net Calls
-$60K
Net Calls Change
-$394K
Top Buyers
| 1 |
Fisher Asset Management
Camas,
Washington
|
$23.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$2.73M |
| 3 |
CA
CHI Advisors
New York
|
$2.35M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$2.63M |
| 5 |
Rafferty Asset Management
New York
|
$3.53M |
